Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age55+
SponsorImelda Hospital, Bonheiden

About this trial

Bone marrow samples will be collected from patients undergoing hip arthroplasty surgery. Blood and bone marrow samples will be used for metabolic profiling and analysis of relevant CHIP mutations. Combined single-cell transcriptomics and mutation-specific single-cell genotyping (biotin-PCR using mutation-targeted primers followed by sequencing) will subsequently be performed. The gene expression profile of wildtype and mutant hematopoietic stem cells will be compared, performing both broad gene set enrichment analysis and targeted analysis of metabolic pathways.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 65 years and older

Disqualifiers

known haematological condition (myelodysplasia, leukemia, cancer)

inability to provide written informed consent

Trial population

Patients undergoing hip arthroplasty for hip osteoarthritis or osteoporotic hip fractures.

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

  • Blood and bone marrow cell collection

    Other intervention

    Collection of blood and bone marrow

Treatment groups

24 Participants
are divided into 2 treatment groups
Group A: Osteoporotic hip fracture patients1 intervention
Group B: Hip osteoarthritis patients1 intervention

Trial outcomes

Primary outcomes

1

Gene Set Enrichment Analysis (GSEA) Normalized Enrichment Score (NES)

Time frame
One day

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Imelda Hospital, Bonheiden

Lead sponsor

Université Catholique de Louvain

Collaborator